Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NovoCare Pharmacy vs Vitalex Health

NovoCare Pharmacy
Graded #442

Lower grade

vs+4.5
Vitalex Health
Graded #337

Higher grade

The verdict

Vitalex Health takes it — 59.7/100 to 55.2/100.

Vitalex Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vitalex Health is an Atlanta-based telehealth practice offering compounded semaglutide, tirzepatide, and a lower-dose GLP-1 microdose program through partner U.S.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitalex Health +30
24
54
Dose & formulationNovoCare Pharmacy +2
66
64
Clinical oversightNovoCare Pharmacy +10
74
64
Labs & monitoringVitalex Health +1
51
52
FulfillmentNovoCare Pharmacy +6
76
70
Contract termsEven
55
55
NovoCare Pharmacy · left barVitalex Health · right bar

The numbers

MetricNovoCare PharmacyVitalex Health
WeighScore55.2/10059.7/100
GradeCC
Scorecard rank#442#337
Semaglutide$349/mo (2.4 mg dose, brand-name)$199/mo (starting dose, compounded)
TirzepatideNot disclosed$199/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
NovoCare Pharmacy

Graded #442 · C

Strengths

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk

Where it loses points

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Vitalex Health

Graded #337 · C

Strengths

  • Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
  • Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
  • Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
  • Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
  • Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links

Where it loses points

  • Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
  • No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
  • Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
  • Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
  • Domain was registered in April 2026 — a brand-new practice with no independent reviews found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard